Methyl 4-(2-oxopyrrolidin-1-yl)benzoate

Catalog No.: 
ACVISK128
CAS No.: 
221381-89-1
Molecular Formula: 
C12H13NO3
Molecular Weight: 
219.24
Methyl 4-(2-oxopyrrolidin-1-yl)benzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$100.00InquiryInquiry
1g97%$198.00InquiryInquiry
5g97%$591.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 4-(2-oxopyrrolidin-1-yl)benzoate
IUPAC Namemethyl 4-(2-oxopyrrolidin-1-yl)benzoate
Molecular FormulaC12H13NO3
Molecular Weight219.24
SMILESO=C(OC)C1=CC=C(N2C(CCC2)=O)C=C1
InChI KeyDKZFCNDOGOKHQH-UHFFFAOYSA-N
SynonymBAS 00358368;CBDivE_015964;ST5449463;ZINC00218245;benzoic acid, 4-(2-oxo-1-pyrrolidinyl)-, methyl ester;methyl 4-(2-oxopyrrolidin-1-yl)benzoate;4-(2-ketopyrrolidin-1-yl)benzoic acid methyl ester;4-(2-oxo-1-pyrrolidinyl)benzoic acid methyl ester
CAS No.221381-89-1

Synthetic Route by SureRoute

1. ACVISK128 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. ACOLWZ209 route compound structure diagram
    ACOLWZ20936151-44-7In Stock
  4. Then
  5. ACVISK128 route product structure diagram
    ACVISK128221381-89-1
Inquiry

2. ACVISK128 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOTKX458 route compound structure diagram
    ACOTKX4581126-46-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVISK128 route product structure diagram
    ACVISK128221381-89-1
Inquiry

3. ACVISK128 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDSAM359 route compound structure diagram
    ACDSAM359619-42-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVISK128 route product structure diagram
    ACVISK128221381-89-1
Inquiry

Comments (0)